Nihon Kohden (OTCMKTS:NHNKY) Issues Quarterly Earnings Results

Nihon Kohden (OTCMKTS:NHNKY) announced its earnings results on Thursday. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10, Zacks reports. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%.

Nihon Kohden Trading Down 1.7%

Shares of Nihon Kohden stock traded down $0.15 during trading hours on Thursday, reaching $8.89. The stock had a trading volume of 11,331 shares, compared to its average volume of 25,064. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 17.43 and a beta of 0.41. Nihon Kohden has a 1 year low of $8.71 and a 1 year high of $14.21. The firm has a 50 day simple moving average of $9.46 and a two-hundred day simple moving average of $10.51.

Analyst Ratings Changes

Several brokerages recently issued reports on NHNKY. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.